Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1260 publications
How do I treat : allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
Journal: Revue medicale de Liege
Published: January 15, 2026
Clinical management and outcomes of hepatobiliary disease in the cystic fibrosis transmembrane conductance regulator modulator era.
Journal: Current opinion in gastroenterology
Published: December 24, 2025
Beyond CFTR: Ivacaftor's role in restoring cellular redox balance and preventing ferroptosis.
Journal: Redox biology
Published: November 14, 2025
Long-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor on Nocturnal Cardiorespiratory Polygraphy Parameters in Patients with Cystic Fibrosis: A Prospective Study.
Journal: Life (Basel, Switzerland)
Published: November 01, 2025
Phenotypic and functional characterisation of liver-infiltrating T-cells in a case of CFTR modulator induced drug-induced liver injury.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 27, 2025
Systemic and airway T cell dynamics with influenza-specific immune recovery by cystic fibrosis elexacaftor/tezacaftor/ivacaftor therapy.
Journal: Respiratory research
Published: October 21, 2025
Lumacaftor and fexofenadine prevent donepezil-induced LQTS via PHE656-mediated hERG chaperoning.
Journal: Biochemical pharmacology
Published: October 15, 2025
Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study.
Journal: International journal of molecular sciences
Published: October 10, 2025
Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis.
Journal: Therapeutic advances in respiratory disease
Published: October 09, 2025
Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR.
Journal: Science progress
Published: October 07, 2025
CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis.
Journal: Cells
Published: October 02, 2025
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy.
Journal: Journal of health psychology
Published: October 02, 2025
Last Updated: 02/24/2026